Cartography Biosciences

Cartography is shaping a world in which cancer immunotherapies are designed around and directed toward the safest, most effective targets.

Cartography is shaping a world in which cancer immunotherapies are designed around and directed toward the safest and most effective targets.

Number of Funding Rounds

Total Funding Amount

1

$57M

Cartography Biosciences has raised a total of $57M in funding over 2 rounds. Their latest funding was raised on Jul 19, 2022 from a Series A round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jul 19, 2022	Series A	$57M	2	—	—	Detail

Number of Lead Investors

Number of Investors

—

2

Cartography Biosciences is funded by 2 investors. Gaingels and National Cancer Research Institute are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gaingels	—	Series A
National Cancer Research Institute	—	Series A